Eduardo Bertolli

402 total citations
39 papers, 225 citations indexed

About

Eduardo Bertolli is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Eduardo Bertolli has authored 39 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Eduardo Bertolli's work include Cutaneous Melanoma Detection and Management (20 papers), Nonmelanoma Skin Cancer Studies (15 papers) and CAR-T cell therapy research (6 papers). Eduardo Bertolli is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), Nonmelanoma Skin Cancer Studies (15 papers) and CAR-T cell therapy research (6 papers). Eduardo Bertolli collaborates with scholars based in Brazil, United States and Netherlands. Eduardo Bertolli's co-authors include João Pedreira Duprat Neto, Mariana Petaccia de Macêdo, Clóvis Antônio Lopes Pinto, Vinícius F. Calsavara, Isabela Werneck da Cunha, Alexander C. J. van Akkooi, Margot Tesselaar, W. Martin C. Klop, Aline Santos Damascena and Vera Tomazella and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Eduardo Bertolli

31 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Bertolli Brazil 10 147 73 46 34 30 39 225
Shachar Sade Canada 10 89 0.6× 67 0.9× 33 0.7× 16 0.5× 15 0.5× 21 218
Gwanghyun Jo South Korea 8 125 0.9× 127 1.7× 57 1.2× 17 0.5× 11 0.4× 52 291
M. Müller Netherlands 6 205 1.4× 104 1.4× 33 0.7× 53 1.6× 84 2.8× 11 310
Wendy R. Cornett United States 6 165 1.1× 32 0.4× 89 1.9× 46 1.4× 35 1.2× 8 291
Shannon C. Trotter United States 9 170 1.2× 127 1.7× 75 1.6× 31 0.9× 13 0.4× 14 299
Charindu K. I. Ranmuthu United Kingdom 6 132 0.9× 69 0.9× 25 0.5× 27 0.8× 15 0.5× 7 265
Georg Lodde Germany 9 71 0.5× 26 0.4× 23 0.5× 51 1.5× 13 0.4× 31 166
Riccardo Bussone Italy 15 98 0.7× 15 0.2× 43 0.9× 210 6.2× 111 3.7× 26 566
Alexander J. Fletcher United Kingdom 8 66 0.4× 40 0.5× 45 1.0× 63 1.9× 108 3.6× 20 280
Laszlo Igali United Kingdom 12 97 0.7× 89 1.2× 34 0.7× 124 3.6× 44 1.5× 34 290

Countries citing papers authored by Eduardo Bertolli

Since Specialization
Citations

This map shows the geographic impact of Eduardo Bertolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Bertolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Bertolli more than expected).

Fields of papers citing papers by Eduardo Bertolli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Bertolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Bertolli. The network helps show where Eduardo Bertolli may publish in the future.

Co-authorship network of co-authors of Eduardo Bertolli

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Bertolli. A scholar is included among the top collaborators of Eduardo Bertolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Bertolli. Eduardo Bertolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, T. S., Barbara Perić, Robyn P.M. Saw, et al.. (2024). Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial. Annals of Surgical Oncology. 31(6). 4061–4070. 1 indexed citations
2.
Bertolli, Eduardo, et al.. (2024). Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies. SHILAP Revista de lepidopterología. 12(3). 35–35. 2 indexed citations
3.
Ferreira, Fábio de Oliveira, et al.. (2024). Damage control surgery in non-traumatic abdominal emergencies: prognostic value of SOFA, APACHEII, and Mannheim peritonitis index. Updates in Surgery. 77(1). 255–262.
4.
Munhoz, Rodrigo Ramella, Guilherme Nader Marta, Veridiana Pires de Camargo, et al.. (2022). A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma. Cancer. 128(24). 4223–4231. 27 indexed citations
5.
Blumetti, Tatiana Cristina Moraes Pinto, et al.. (2022). Melanoma with peripheral globules: Clinical and dermatoscopic features. Journal of the American Academy of Dermatology. 87(3). 567–572. 3 indexed citations
6.
Bertolli, Eduardo, et al.. (2022). Intraoperative assessment of surgical margins using “en face” frozen sections in the management of cutaneous carcinomas. Anais Brasileiros de Dermatologia. 97(5). 583–591. 5 indexed citations
7.
Bertolli, Eduardo, et al.. (2022). Management of In-Transit Metastases. Current Oncology Reports. 24(5). 573–583. 2 indexed citations
8.
Bertolli, Eduardo, et al.. (2022). Manejo de defeitos complexos do couro cabeludo após excisão de tumores malignos. Revista Brasileira de Cirurgia Plástica. 37(4).
9.
Bertolli, Eduardo, et al.. (2022). Management of complex scalp defects after excision of malignant tumors. SHILAP Revista de lepidopterología. 37(4).
11.
12.
Pinto, Clóvis Antônio Lopes, et al.. (2020). Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients. Annals of Surgical Oncology. 27(11). 4133–4140. 9 indexed citations
13.
Pellizzon, Antônio Cássio Assis, et al.. (2020). The Role of Radiation Therapy as an Adjuvant Treatment in Nodal Metastasis of Malignant Chondroid Syringoma. Cureus. 12(11). e11360–e11360. 1 indexed citations
14.
Bertolli, Eduardo, et al.. (2020). The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC). Annals of Surgical Oncology. 28(2). 1019–1028. 17 indexed citations
15.
Neto, João Pedreira Duprat, Eduardo Bertolli, Isabela Werneck da Cunha, et al.. (2018). Relapse in dermatofibrosarcoma protuberans: A histological and molecular analysis. Journal of Surgical Oncology. 117(5). 845–850. 11 indexed citations
16.
Bertolli, Eduardo, Viola Franke, Vinícius F. Calsavara, et al.. (2018). Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian–Dutch Study. Annals of Surgical Oncology. 26(2). 395–405. 12 indexed citations
17.
Bertolli, Eduardo, et al.. (2015). Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients. Melanoma Research. 26(1). 42–45. 8 indexed citations
19.
Neto, João Pedreira Duprat, et al.. (2012). Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity. Clinics. 67(3). 237–241. 12 indexed citations
20.
Bertolli, Eduardo, et al.. (2002). Tratamento da anemia com eritropoetina recombinante humana em pacientes hemodialisados. Revista da Faculdade de Ciências Médicas de Sorocaba. 4. 31–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026